Political Hedge

Biotech investors sound alarm on Senate drug-pricing bill

A group of biotech investors and doctors are warning that the Senate’s drug-pricing proposal, aimed at lowering skyrocketing prices, would “strike a huge blow” to patient access and halt research on new treatments for Alzheimer’s disease, heart disease and cancer.

Share this Story
Load More Related Articles
Load More In Political Hedge